Lung cancer screening

Oncologist

Volumn 11, Issue 5, 2006, Pages 481-487

  Ganti, Apar Kishor ^a   Mulshine, James L ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NONE

Author keywords

Computerized tomographic scans; Lung cancer; Spiral CT screening

Indexed keywords

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; GENOMICS; HEALTH CARE ORGANIZATION; HIGH RISK POPULATION; HUMAN; IMAGING SYSTEM; LUNG CANCER; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SPUTUM ANALYSIS; THORAX RADIOGRAPHY;

COST-BENEFIT ANALYSIS; HUMANS; LUNG NEOPLASMS; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 33646860981     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.11-5-481     Document Type: Review

References (64)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999;49:33-64, 31.
2. Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
3. Wingo PA, Ries LA, Giovino GA et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 1999;91:675-690.
4. Capewell S, Sankaran R, Lamb D et al. Lung cancer in lifelong non-smokers. Edinburgh Lung Cancer Group. Thorax 1991;46:565-568.
5. Tong L, Spitz MR, Fueger JJ et al. Lung carcinoma in former smokers. Cancer 1996;78:1004-1010.
6. Fellows JL, Trosclair A. Annual smoking-attributable mortality, years of potential life lost and economic cost - United States 1005-1999. Morb Mortal Wkly Rep 2002;51:300-303.
7. Mountain CF. A new international staging system for lung cancer. Chest 1986;89:225S-233S.
8. Shimizu J, Watanabe Y, Oda M et al. [Results of surgical treatment of stage I lung cancer]. Nippon Geka Gakkai Zasshi 1993;94:505-510. Japanese.
9. Mountain CF, Lukeman JM, Hammar SP et al. Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population. J Surg Oncol 1987;35:147-156.
10. Williams DE, Pairolero PC, Davis CS et al. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 1981;82:70-76.
11. Martini N. Surgical treatment of lung cancer. Semin Oncol 1990;17(suppl 7):9-10.
12. Shah R, Sabanathan S, Richardson J et al. Results of surgical treatment of stage I and II lung cancer. J Cardiovasc Surg (Torino) 1996;37:169-172.
13. Wilson JM, Jungner YG. [Principles and practice of mass screening for disease.] Bol Oficina Sanit Panam 1968;65:281-393. Spanish.
14. Brett GZ. Earlier diagnosis and survival in lung cancer. Br Med J 1969;4:260-262.
15. Fontana RS, Sanderson DR, Woolner LB et al. Lung cancer screening: the Mayo program. J Occup Med 1986;28:746-750.
16. Fontana RS, Sanderson DR, Woolner LB et al. Screening for lung cancer. A critique of the Mayo Lung Project. Cancer 1991;67:1155-1164.
17. Kubik A, Polak J. Lung cancer detection. Results of a randomized prospective study in Czechoslovakia. Cancer 1986;57:2427-2437.
18. Melamed MR, Flehinger BJ, Zaman MB et al. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 1984;86:44-53.
19. Tockman M. Survival and mortality from lung cancer in a screened population: The John Hopkins study. Chest 1986;89:325S.
20. Ganti AK, Mulshine JL. Lung cancer screening: panacea or pipe dream? Ann Oncol 2005;16(suppl 2):ii215-ii219.
21. Bastarrika G, Pueyo JC, Mulshine JL. Radiologic screening for lung cancer. Expert Rev Anticancer Ther 2002;2:385-392.
22. Kaneko M, Eguchi K, Ohmatsu H et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996;201:798-802.
23. Sone S, Takashima S, Li F et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998;351:1242-1245.
24. Henschke CI, McCauley DI, Yankelevitz DF et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105.
25. Henschke CI. Early Lung Cancer Action Project: overall design and findings from baseline screening. Cancer 2000;89:2474-2482.
26. Henschke CI, Sone S, Markowitz S. International Early Lung Cancer Action Project (I-ELCAP): evaluation of low-dose CT screening. Proceedings of the Annual Meeting of the Radiological Society of North America, Chicago, Illinois, November 28-December 3, 2004.
27. Swensen SJ, Jett JR, Sloan JA et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002;165:508-513.
28. Pastorino U, Bellomi M, Landoni C et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003;362:593-597.
29. Sobue T, Moriyama N, Kaneko M et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 2002;20:911-920.
30. Mulshine JL, Sullivan DC. Clinical practice. Lung cancer screening. N Engl J Med 2005;352:2714-2720.
31. Humphrey LL, Teutsch S, Johnson M. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2004;140:740-753.
32. Gohagan JK, Marcus PM, Fagerstrom RM et al. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 2005;47:9-15.
33. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-1892.
34. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-1886.
35. Swensen SJ, Jett JR, Hartman TE et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005;235:259-265.
36. Patz EF Jr, Goodman PC. Low-dose spiral computed tomography screening for lung cancer: not ready for prime time. Am J Respir Crit Care Med 2001;163:813-814.
37. Grannis FW Jr. Lung cancer overdiagnosis bias: "the gyanousa am loose!" Chest 2001;119:322-323.
38. Heffner JE, Silvestri G. CT screening for lung cancer: is smaller better? Am J Respir Crit Care Med 2002;165:433-434.
39. McFarlane MJ, Feinstein AR, Wells CK. Clinical features of lung cancers discovered as a postmortem "surprise". Chest 1986;90:520-523.
40. Bianchi F, Hu J, Pelosi G et al. Lung cancers detected by screening with spiral computed tomography have a malignant phenotype when analyzed by cDNA microarray. Clin Cancer Res 2004;10:6023-6028.
41. Swensen SJ, Jett JR, Hartman TE et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003;226:756-761.
42. Henschke CI, Yankelevitz DF, Libby D et al. CT screening for lung cancer: the first ten years. Cancer J 2002;8(suppl 1):S47-S54.
43. Henschke CI, Yankelevitz DF, Naidich DP et al. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology 2004;231:164-168.
44. Crestanello JA, Allen MS, Jett JR et al. Thoracic surgical operations in patients enrolled in a computed tomographic screening trial. J Thorac Cardiovasc Surg 2004;128:254-259.
45. Romano PS, Mark DH. Patient and hospital characteristics related to in-hospital mortality after lung cancer resection. Chest 1992;101:1332-1337.
46. Libby DM, Smith JP, Altorki NK et al. Managing the small pulmonary nodule discovered by CT. Chest 2004;125:1522-1529.
47. Mahadevia PJ, Fleisher LA, Frick KD et al. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. JAMA 2003;289:313-322.
48. Wisnivesky JP, Mushlin AI, Sicherman N et al. The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening. Chest 2003;124:614-621.
49. Manser R, Dalton A, Carter R et al. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting. Lung Cancer 2005;48:171-185.
50. Brenner DJ. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology 2004;231:440-445.
51. Diederich S, Wormanns D, Heindel W. Low-dose CT: new tool for screening lung cancer? Eur Radiol 2001;11:1916-1924.
52. Lenzen H, Roos N, Diederich S et al. [Radiation exposure in low dose computerized tomography of the thorax]. Radiologe 1996;36:483-488. German.
53. Reeves AP, Kostis WJ. Computer-aided diagnosis for lung cancer. Radiol Clin North Am 2000;38:497-509.
54. Wormanns D, Fiebich M, Saidi M et al. Automatic detection of pulmonary nodules at spiral CT: clinical application of a computer-aided diagnosis system. Eur Radiol 2002;12:1052-1057.
55. Clarke LP, Croft BY, Staab E et al. National Cancer Institute initiative: lung image database resource for imaging research. Acad Radiol 2001;8:447-450.
56. Liloglou T, Maloney P, Xinarianos G et al. Cancer-specific genomic instability in bronchial lavage: a molecular tool for lung cancer detection. Cancer Res 2001;61:1624-1628.
57. Cuda G, Gallelli A, Nistico A et al. Detection of microsatellite instability and loss of heterozygosity in serum DNA of small and non-small cell lung cancer patients: a tool for early diagnosis? Lung Cancer 2000;30:211-214.
58. Esteller M, Sanchez-Cespedes M, Rosell R et al. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999;59:67-70.
59. Chen XQ, Stroun M, Magnenat JL et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996;2:1033-1035.
60. Sozzi G, Musso K, Ratcliffe C et al. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis. Clin Cancer Res 1999;5:2689-2692.
61. Sozzi G, Conte D, Leon M et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003;21:3902-3908.
62. Tockman MS, Gupta PK, Myers JD et al. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J Clin Oncol 1988;6:1685-1693.
63. Chaurand P, Stoeckli M, Caprioli RM. Direct profiling of proteins in biological tissue sections by MALDI mass spectrometry. Anal Chem 1999;71:5263-5270.
64. Wardwell NR, Massion PP. Novel strategies for the early detection and prevention of lung cancer. Semin Oncol 2005;32:259-268.